United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
608.49
+7.17 (1.19%)
Nov 4, 2026, 4:00 PM EST - Market closed

United Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,1891,5571,6971,208961.2894.8
Short-Term Investments
8791,3631,5701,7861,8781,036
Cash & Short-Term Investments
2,0682,9203,2672,9942,8391,931
Cash Growth
-25.28%-10.61%9.12%5.47%47.03%5.21%
Accounts Receivable
348.6350.2279.3278.9220.4198.7
Other Receivables
---2170-
Receivables
348.6350.2279.3299.9290.4198.7
Inventory
201.9183.1157.9111.810293.8
Other Current Assets
261.8248.9169.7145.2149.2100.4
Total Current Assets
2,8803,7033,8743,5513,3802,324
Property, Plant & Equipment
2,0421,7301,2221,045861.5780.9
Long-Term Investments
1,4681,8311,5341,9381,3451,681
Goodwill
-32.332.333.72828
Other Intangible Assets
114.684.279.680.516.516.6
Long-Term Deferred Tax Assets
270.2357.7458.4394.8327.7261.9
Other Long-Term Assets
259.4143.1163.1123.385.877.1
Total Assets
7,0347,8807,3647,1676,0455,169

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
520.27.165.64.13.8
Accrued Expenses
-506.9369.3358.3326.1291.4
Current Portion of Long-Term Debt
--300400--
Current Portion of Leases
-7.3----
Other Current Liabilities
104.139.362.840.51310.2
Total Current Liabilities
624.3560.6738.1804.4343.2305.4
Long-Term Debt
---300800800
Long-Term Leases
-30.3----
Pension & Post-Retirement Benefits
-28.821.318.33248.9
Other Long-Term Liabilities
133.8164.1160.659.572.655.9
Total Liabilities
758.1783.89201,1821,2481,210

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.80.80.80.70.70.7
Additional Paid-In Capital
3,0212,7982,6992,5492,3882,245
Retained Earnings
9,4238,5577,2226,0275,0424,315
Treasury Stock
-6,139-4,260-3,475-2,579-2,579-2,579
Comprehensive Income & Other
-30.30.9-3.4-12.8-55.5-23
Shareholders' Equity
6,2767,0966,4445,9854,7973,959
Total Liabilities & Equity
7,0347,8807,3647,1676,0455,169

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-37.6300700800800
Net Cash (Debt)
3,5364,6594,4424,2043,3552,781
Net Cash Growth
-18.44%4.89%5.67%25.31%20.65%27.28%
Net Cash Per Share
76.2097.2791.5984.5969.1758.79
Filing Date Shares Outstanding
42.5943.8344.9147.0646.345.13
Total Common Shares Outstanding
42.3843.6444.8347.0446.0345.11
Working Capital
2,2563,1423,1362,7473,0372,018
Book Value Per Share
148.08162.60143.74127.23104.2087.77
Tangible Book Value
6,1616,9806,3325,8714,7523,914
Tangible Book Value Per Share
145.38159.93141.24124.80103.2486.78
Land
-266.5181.9148142.7132.6
Buildings
-944.7863.8685.3636.7612.7
Machinery
-493.6449.7381.2353.9322.9
Construction In Progress
-592.7218.2259.1110.955.1
SEC Filings: 10-K · 10-Q